ArticleOncoTargets and therapy2018

Overexpression of GPR35 confers drug resistance in NSCLC cells by β-arrestin/Akt signaling.

Wei Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.